Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Ekologia - Ecology Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudba 2025Webshop Cart
Bratislava Medical Journal Vol.116, No.4, p.205-211, 2016 |
||
Title: Relapse rates of inflammatory bowel disease patients in deep and clinical remission after discontinuing anti-tumor necrosis factor alpha therapy | ||
Author: T. Hlavaty, A. Krajcovicova, J. Letkovsky, I. Sturdik, T. Koller, J. Toth, M. Huorka | ||
Abstract: BACKGROUND AND AIMS: Relapse rates after discontinuing anti-tumor necrosis factor-α (TNFα) therapy of inflammatory bowel disease (IBD) patients in deep remission are poorly understood. This prospective single-center open-label study evaluated the relapse rates of IBD patients after stopping anti-TNFα therapy.
|
||
Keywords: Crohn’s disease, ulcerative colitis, infliximab, adalimumab, treatment discontinuation, relapse rate | ||
Published online: 04-Apr-2016 | ||
Year: 2016, Volume: 116, Issue: 4 | Page From: 205, Page To: 211 | |
doi:10.4149/BLL_2016_039 |
||
|
![]() |
|